Fetal Monitoring, Diagnostics and Predictive Tests

Report Highlights

The global market for fetal monitoring, prenatal diagnostics, predictive tests and neonatal monitoring was valued at roughly $8.6 billion in 2013 and about $9.0 billion in 2014. This market is expected to reach about $10.9 billion by 2019, with a compound annual growth rate (CAGR) of 4.0% from 2014 to 2019.

Report Includes

• An overview of the global markets for fetal monitoring, diagnostics, and predictive tests.
• Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
• Information on the strengths and weaknesses of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers.
• Discussion covering acquisitions, mergers, and alliances by companies and global organizations.
• Comprehensive company profiles of major players in the industry.

SCOPE OF THE STUDY

This study is mainly focused on fetal monitoring and related markets. Therefore, it does not focus on neonatal monitoring. The study is focused on fetal diseases, fetal monitoring products, diagnostic and predictive tests. The study has listed almost all the participating companies in the fetal monitoring sector and their products relevant to this field.

ANALYST’S CREDENTIALS

This study was carried out by retired professor P. Natana Raj, who holds a master’s degree in biology. He also holds diplomas in biochemistry, biotechnology, biochemical pharmacology, environmental biology and plant embryology. He has 34 years of experience in teaching biochemistry, biotechnology, pharmacology, molecular biology and genetics. Since 2007, he has authored 26 market research reports in the health care sector.